SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades

Rhea-AI Filing Summary

SOPHiA GENETICS SA is registering a proposed sale of 20,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $133,800.00 as of the filing, and an anticipated sale date of August 7, 2026.

The filing also lists prior Rule 10b5-1 plan sales of common shares by Jurgi Camblong over the past three months, including transactions such as 65,269 shares sold on June 30, 2026 for $398,632.27 and 50,069 shares sold on June 26, 2026 for $290,329.01.

Key Figures

Shares proposed for sale: 20,000 shares Aggregate market value of proposed sale: $133,800.00 Proposed sale date: 08/07/2026 +3 more

6 metrics

Shares proposed for sale 20,000 shares Common stock covered by the Form 144 notice

Aggregate market value of proposed sale $133,800.00 Value associated with the 20,000 shares of common stock

Proposed sale date 08/07/2026 Anticipated date of the Rule 144 sale

10b5-1 sale on June 30, 2026 65,269 shares for $398,632.27 Common stock sold in a single Rule 10b5-1 transaction

10b5-1 sale on June 26, 2026 50,069 shares for $290,329.01 Common stock sold in a single Rule 10b5-1 transaction

10b5-1 sale on July 20, 2026 24,381 shares for $153,445.04 Common stock sold in a single Rule 10b5-1 transaction

Key Terms

Rule 144, 10b5-1 Sales, Founders Shares

3 terms

Rule 144 regulatory

"144: Securities Information Common ... 144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Founders Shares financial

"Common | 03/18/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:33 PM Accepted by SEC EDGAR 08/07/2026 - 04:33 PM Learn about SEC filing dates

FAQ

What does SOPH’s latest Form 144 filing disclose?

The filing discloses a planned sale of 20,000 shares of SOPHiA GENETICS SA common stock with an aggregate market value of $133,800.00, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many SOPH shares are proposed to be sold under this Form 144?

The Form 144 covers a proposed sale of 20,000 shares of SOPHiA GENETICS SA common stock under Rule 144, with an indicated aggregate market value of $133,800.00 tied to the filing.

Who is associated with the recent SOPH Rule 10b5-1 sales?

The filing lists Jurgi Camblong in connection with a series of Rule 10b5-1 plan sales of SOPHiA GENETICS SA common stock over the past three months, with multiple dated transactions and share amounts disclosed.

What is one of the larger recent SOPH share sales under the 10b5-1 plan?

One of the larger reported transactions is the sale of 65,269 common shares on June 30, 2026 for total proceeds of $398,632.27, as part of Rule 10b5-1 plan sales associated with Jurgi Camblong.

Does SOPH’s Form 144 mention prior sales in the past three months?

Yes. It lists multiple past three-month sales of SOPHiA GENETICS SA common stock under a Rule 10b5-1 plan, including 50,069 shares sold on June 26, 2026 for $290,329.01 and other dated transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	133800.00	85127825	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			20000	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	08/04/2026	20000	138412.00
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2026	20000	132654.00
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/20/2026	24381	153445.04
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/10/2026	8500	47791.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2026	17685	93327.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	22486	118163.93
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/30/2026	65269	398632.27
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/29/2026	18410	108058.02
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/26/2026	50069	290329.01
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)